LARONI, ALICE
 Distribuzione geografica
Continente #
NA - Nord America 329
EU - Europa 228
AS - Asia 97
SA - Sud America 8
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 667
Nazione #
US - Stati Uniti d'America 323
IT - Italia 62
CN - Cina 55
IE - Irlanda 55
SE - Svezia 33
VN - Vietnam 25
UA - Ucraina 19
DE - Germania 12
FR - Francia 11
GB - Regno Unito 11
ES - Italia 6
CA - Canada 4
CH - Svizzera 4
CO - Colombia 4
PL - Polonia 4
AR - Argentina 3
BE - Belgio 3
KR - Corea 3
SA - Arabia Saudita 3
AT - Austria 2
AU - Australia 2
IR - Iran 2
JP - Giappone 2
SG - Singapore 2
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
IN - India 1
IQ - Iraq 1
MX - Messico 1
NG - Nigeria 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 667
Città #
Chandler 113
Dublin 55
Beijing 37
Jacksonville 20
Medford 20
Fairfield 18
Dong Ket 17
Princeton 17
Nyköping 16
Wilmington 15
Ann Arbor 12
Torino 11
Hangzhou 10
Milan 9
Houston 8
Redwood City 7
Boston 4
Hanover 4
Naples 4
Woodbridge 4
Ashburn 3
Brussels 3
San Diego 3
Seattle 3
Seoul 3
Toronto 3
Berlin 2
Bogotá 2
Brisbane 2
Cambridge 2
Chengdu 2
Dearborn 2
Genoa 2
King of Prussia 2
Langhorne 2
Lodz 2
London 2
Madrid 2
Malmo 2
Manchester 2
Nanjing 2
Norwalk 2
Paris 2
Pereira 2
Reus 2
Rockville 2
Tamworth 2
Treviso 2
Union City 2
Vienna 2
Villeurbanne 2
Washington 2
Wuhan 2
Anacapri 1
Ancona 1
Athens 1
Atlanta 1
Baghdad 1
Bengaluru 1
Biblis 1
Brooklyn 1
Caserta 1
Central District 1
Conegliano 1
Copenhagen 1
Dornstadt 1
Durham 1
Fair Lawn 1
Florence 1
Frankfurt am Main 1
Fremont 1
Granada 1
Groningen 1
Honolulu 1
Iglesias 1
Istanbul 1
Kiel 1
Lagny-sur-Marne 1
Lagos 1
Leawood 1
Mendoza 1
Mestre 1
Mexico City 1
Milicz 1
Montréal 1
Nashville 1
New York 1
Nottwil 1
Oslo 1
Palma 1
Redmond 1
Rennes 1
Riverton 1
Rome 1
Ronnenberg 1
Roseau 1
San Justo 1
Santos 1
Silver Spring 1
Tehran 1
Totale 520
Nome #
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 112
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 96
A real-world study of Alemtuzumab in a cohort of Italian patients 44
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 42
Comparative effectiveness of dimethyl fumarate, teriflunomide, interferon-beta and glatiramer acetate on newly diagnosed patients: a propensity score-matched analysis from a multicenter Italian group 41
Early diagnosis of progressive multifocal leucoencephalopathy: Longitudinal lesion evolution 40
Comparative effectiveness of Cladribine tablets vs other drugs in relapsing-remitting multiple sclerosis: an approach merging randomized controlled trial with real life data 37
Switching to alemtuzumab from fingolimod or other therapies: impact of wash-out period on disease activity 36
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study 35
Shift from fingolimod to alemtuzumab: what happens next? 33
Extended interval dosing of natalizumab: is efficacy preserved? 33
A Real-Life Study of Alemtuzumab: Impact of Previous Therapies and Washout Period on Disease Activity 32
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 29
To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy 27
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 26
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 18
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 17
Totale 698
Categoria #
all - tutte 1443
article - articoli 0
book - libri 0
conference - conferenze 581
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20188 0000 00 03 4100
2018/201914 1040 00 06 1110
2019/202043 3006 26 30 1598
2020/2021130 20133 125 87 1061432
2021/2022200 271113 2010 169 5244439
2022/2023297 34382525 5096 290 0000
Totale 698